Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Cancers|September 23, 2022
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III TrialMarkus Diefenhardt, Daniel Martin, Ethan B Ludmir, et al.
Cancers|August 29, 2024
Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic ModelHanzhi Wang, Linsey Gong, Xiaoyong Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2025
Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 TrialRebekka Kosmala, Adriana Salazar Hammann, Patrick Paulus, et al.
EMBO Molecular Medicine|December 10, 2016
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapyAbul Azad, Su Yin Lim, Zenobia D'Costa, et al.
Hepatology (Baltimore, Md.)|January 31, 2017
Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in miceAlex N Gordon-Weeks, Su Y Lim, Arseniy E Yuzhalin, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trialEmmanouil Fokas, Torsten Liersch, Rainer Fietkau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trialsMarkus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Cancers|September 23, 2022
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III TrialMarkus Diefenhardt, Daniel Martin, Ethan B Ludmir, et al.
Cancers|August 29, 2024
Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic ModelHanzhi Wang, Linsey Gong, Xiaoyong Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2025
Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 TrialRebekka Kosmala, Adriana Salazar Hammann, Patrick Paulus, et al.
EMBO Molecular Medicine|December 10, 2016
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapyAbul Azad, Su Yin Lim, Zenobia D'Costa, et al.
Hepatology (Baltimore, Md.)|January 31, 2017
Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in miceAlex N Gordon-Weeks, Su Y Lim, Arseniy E Yuzhalin, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trialEmmanouil Fokas, Torsten Liersch, Rainer Fietkau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trialsMarkus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Cancers|December 2, 2020
Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 TrialKatharina J Wenger, Marlies Wagner, Patrick N Harter, et al.
Pageof 16